To assess whether the high CD44 expression observed in BMAT-rich sites was exclusive to T-ALL or may also occur in B-ALL, we analyzed CD44 expression in three B-ALL samples from different oncogenic groups (Supplementary Table 1). This evidence concerns the gene CD44 and acute lymphoblastic leukemia.